According to the report, the global prenatal DNA sequencing market was USD 1,083 million in 2018 and is expected to generate around USD 2,605 million by 2025, growing at a CAGR of around 13.37% between 2019 and 2025.

New York, NY, Aug. 28, 2019 (GLOBE NEWSWIRE) — Zion Market Research has published a new report titled “Prenatal DNA Sequencing Market By Application (Hemophilia, Down Syndrome, Cystic Fibrosis, Autism, DiGeorge Syndrome, AIDS, Cancer, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global prenatal DNA sequencing market was USD 1,083 million in 2018 and is expected to generate around USD 2,605 million by 2025, growing at a CAGR of around 13.37% between 2019 and 2025.

DNA sequencing is defined as a process that is used to determine the order or sequence of nucleotides within DNA particles. Prenatal DNA sequencing is a DNA sequencing method extracted from an expectant women’s blood to disclose the full genetic code of a fetus. It is used to structure the whole genome of an unborn baby, which helps in effectively detecting the diseases cystic fibrosis, down syndrome, cancer, etc.

Browse through 20 Tables & 21 Figures spread over 110 Pages and in-depth TOC on “Global Prenatal DNA Sequencing Market Size & Share 2018: By Type, Size, Share, Industry Applications, Trends, Analysis and Forecast 2025”.

Request Free Sample Report of Global Prenatal DNA Sequencing Market @ https://www.zionmarketresearch.com/sample/prenatal-dna-sequencing-market

There are various factors driving the prenatal DNA sequencing market globally. The demand for prenatal DNA sequencing technology is increasing rapidly in the global market, due to the introduction of new technologies of DNA sequencing process and increasing incidences of chronic diseases like cancer and AIDS, among others. In addition, increasing R&D investments for preventing chronic diseases also contribute to the prenatal DNA sequencing market globally. However, the high cost of DNA sequencing may be a major restraining factor affecting the prenatal DNA sequencing market development in the years ahead.

The prenatal DNA sequencing market is segmented on the basis of application and region. The application segment is divided into the down syndrome, hemophilia, cystic fibrosis, AIDS, DiGeorge syndrome, autism, cancer, and others. Genetic diseases, such as AIDS, hemophilia, and down syndrome, holds the largest market share and are expected to dominate the prenatal DNA sequencing market in terms of revenue in the years ahead, owing to the increasing cases of AIDS, cancer, and other chronic diseases.

Request for PDF Brochure of This Report: https://www.zionmarketresearch.com/requestbrochure/prenatal-dna-sequencing-market

North America dominates the prenatal DNA sequencing market globally, due to the rising number of genetic diseases that require an increased number of hospitals for treatment. The U.S is the main market players, due to the availability of advanced healthcare infrastructure, technological improvements in DNA sequencing, and growing R&D investment in prenatal DNA sequencing technology. In addition, the regional presence of leading market players also helps in boosting the region’s prenatal DNA sequencing market.

Europe held the second spot of the prenatal DNA sequencing market share in 2018, due to its wide and effective applications of prenatal DNA sequencing across the region. Germany and the U.K. are major contributors to the European prenatal DNA sequencing market.

Browse the full “Prenatal DNA Sequencing Market By Application (Hemophilia, Down Syndrome, Cystic Fibrosis, Autism, DiGeorge Syndrome, AIDS, Cancer, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” Report at https://www.zionmarketresearch.com/report/prenatal-dna-sequencing-market

The Asia Pacific prenatal DNA sequencing market is the fastest-growing region that shall register the highest CAGR over the forecast time period. The key factors driving this regional market are growing population base, rising number of patients suffering from cancer, AIDS, etc., and increasing healthcare expenditure. Improving healthcare infrastructure for establishing advanced technology also contributes to the growth of the region’s prenatal DNA sequencing market.

Latin America is another important regional market for prenatal DNA sequencing, which is estimated to witness moderate growth rate over the forecast time period. This can be attributed to the increasing healthcare expenditure in terms of highly advanced techniques and methods, such as the use of prenatal DNA sequencing to determine the genetic code of a fetus.

Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/prenatal-dna-sequencing-market

The Middle East and Africa prenatal DNA sequencing market will show sluggish growth in the future, owing to the lack of funding required for the implementation of prenatal DNA sequencing technique due to the high installation costs.

Some major players in the prenatal DNA sequencing market are Agilent Technologies, F. Hoffmann-La Roche, Laboratory Corporation of America, Natera, Genomic Health, Myriad Genetics, Invitae, BGI, and Illumina.

Request customized copy of report @ https://www.zionmarketresearch.com/custom/4630

This report segments the global prenatal DNA sequencing market into:

Global Prenatal DNA Sequencing Market: By Application

• Hemophilia
• DiGeorge Syndrome
• Cystic Fibrosis
• Down Syndrome
• Autism
• Cancer
• AIDS
• Others

Global Prenatal DNA Sequencing Market: By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa

Related Reports:

• Cell Based Assay Market: https://www.zionmarketresearch.com/report/cell-based-assay-market
• Agricultural Biotechnology Market: https://www.zionmarketresearch.com/report/agricultural-biotechnology-market
• Genome Editing Market: https://www.zionmarketresearch.com/report/genome-editing-genome-engineering-market
• Apoptosis Assays Market: https://www.zionmarketresearch.com/report/apoptosis-assays-market
• RNA Based Therapeutics Market: https://www.zionmarketresearch.com/report/rna-based-therapeutics-market                                                                         

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research

Visit Our Blog:  http://zmrnewsnetwork.com | http://www.clickfeaturetech.com | https://prosampleresume.com

Contact Us:

Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com

Website: https://www.zionmarketresearch.com

Blog: http://newszmr.com